nicardipine has been researched along with Arteriosclerosis in 6 studies
Nicardipine: A potent calcium channel blockader with marked vasodilator action. It has antihypertensive properties and is effective in the treatment of angina and coronary spasms without showing cardiodepressant effects. It has also been used in the treatment of asthma and enhances the action of specific antineoplastic agents.
nicardipine : A racemate comprising equimolar amounts of (R)- and (S)-nicardipine. It is a calcium channel blocker which is used to treat hypertension.
2-[benzyl(methyl)amino]ethyl methyl 2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate : A dihydropyridine that is 1,4-dihydropyridine substituted by a methyl, {2-[benzyl(methyl)amino]ethoxy}carbonyl, 3-nitrophenyl, methoxycarbonyl and methyl groups at positions 2, 3, 4, 5 and 6, respectively.
Arteriosclerosis: Thickening and loss of elasticity of the walls of ARTERIES of all sizes. There are many forms classified by the types of lesions and arteries involved, such as ATHEROSCLEROSIS with fatty lesions in the ARTERIAL INTIMA of medium and large muscular arteries.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The effect of nicardipine on experimental hyperlipemia induced by a 1% cholesterol diet in spontaneously hypertensive rats (SHR) was investigated by the change of hemodynamics and the determination of lipid contents of the serum, liver, heart and aorta." | 3.67 | [Effect of nicardipine on cholesterol-fed S.H.R]. ( Kawashima, I; Nakayama, S; Ohba, T; Sakamoto, K; Tonooka, M; Yasuhara, H, 1985) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 5 (83.33) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (16.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chiba, T | 1 |
| Yamanaka, M | 1 |
| Takagi, S | 1 |
| Shimizu, K | 1 |
| Takahashi, M | 1 |
| Shirai, K | 1 |
| Takahara, A | 1 |
| Naito, M | 1 |
| Kuzuya, F | 1 |
| Asai, K | 1 |
| Shibata, K | 1 |
| Yoshimine, N | 1 |
| Koibuchi, Y | 1 |
| Sakai, S | 1 |
| Miura, S | 1 |
| Ono, T | 1 |
| Shibayama, F | 1 |
| Ohtsuka, M | 1 |
| Mori, S | 1 |
| Ito, H | 1 |
| Yamamoto, K | 1 |
| Henry, PD | 1 |
| Ohba, T | 1 |
| Tonooka, M | 1 |
| Kawashima, I | 1 |
| Nakayama, S | 1 |
| Yasuhara, H | 1 |
| Sakamoto, K | 1 |
1 review available for nicardipine and Arteriosclerosis
| Article | Year |
|---|---|
Atherosclerosis, calcium, and calcium antagonists.
Topics: Animals; Aorta; Arteries; Arteriosclerosis; Calcinosis; Calcium; Calcium Channel Blockers; Cell Surv | 1985 |
5 other studies available for nicardipine and Arteriosclerosis
| Article | Year |
|---|---|
Cardio-ankle vascular index (CAVI) differentiates pharmacological properties of vasodilators nicardipine and nitroglycerin in anesthetized rabbits.
Topics: Anesthesia; Animals; Ankle Brachial Index; Arteriosclerosis; Blood Pressure; Brachial Artery; Dose-R | 2015 |
Ineffectiveness of Ca2+-antagonists nicardipine and diltiazem on experimental atherosclerosis in cholesterol-fed rabbits.
Topics: Animals; Aorta; Arteriosclerosis; Benzazepines; Calcium; Cholesterol; Cholesterol, Dietary; Choleste | 1984 |
Suppression of atherogenesis in cholesterol-fed rabbits treated with nilvadipine, a new vasoselective calcium entry blocker.
Topics: Animals; Aorta, Thoracic; Arteriosclerosis; Blood Pressure; Calcium; Calcium Channel Blockers; Chole | 1989 |
Effects of calcium antagonists on low density lipoprotein metabolism in human arterial smooth muscle cells.
Topics: Arteriosclerosis; Calcium Channel Blockers; Cells, Cultured; Humans; Lipoproteins, LDL; Muscle, Smoo | 1988 |
[Effect of nicardipine on cholesterol-fed S.H.R].
Topics: Animals; Aorta; Arteriosclerosis; Body Weight; Heart Rate; Hyperlipidemias; Hypertension; Lipids; Li | 1985 |